Yu Wang

Dr. Yu Wang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Epilepsy & Behavior
Verified
Journal Article
Closed access
YJYubao Jiang
Yubao Jiang
YHYing Hu
Ying Hu
YWYu Wang
Yu Wang
NZNong Zhou
Nong Zhou
LZLi Zhu
Li Zhu
KWKai Wang
Kai Wang

23 September 2011 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
YWYu Wang
Yu Wang
PLPing‐Ping Liu
Ping‐Ping Liu
LLLiang‐Yong Li
Liang‐Yong Li
HZHui‐Min Zhang
Hui‐Min Zhang
TLTao Li
Tao Li

8 December 2020 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
LWLong Wang
Long Wang
JZJuan Zhang
Juan Zhang
ZDZi‐Ru Deng
Zi‐Ru Deng
MZMei‐Dan Zu
Mei‐Dan Zu
YWYu Wang
Yu Wang
Objective: Recent studies have shown a pathophysiologic link between headache and multiple sclerosis (MS), but the prevalence of primary headaches among patients with MS differs substantially across studies. This meta‐analysis aimed to comprehensively gather available evidence to estimate the prevalence of primary headaches among patients with MS.Method: We systematically searched the electronic databases including PubMed, Embase, and Scopus for cohort, case–control, cross‐sectional studies that measured the prevalence of headache among patients with MS. Two reviewers independently screened titles and abstracts to identify the eligible studies and the full texts of the included studies were reviewed. Newcastle‐Ottawa Scale (NOS) was used to assess the risk of bias of the included literatures. We then conducted a meta‐analysis using Stata Software 15.0 to calculate the pooled prevalence of headaches among patients with MS and assess the source of heterogeneity.Results: We identified 16 eligible studies covering a total of 3,560 patients with MS. The pooled estimated prevalence of primary headaches among patients with MS was 56%. The statistical heterogeneity was moderate with I2 of 82.1% (p < .001). Both a visual inspection of the funnel plot and Egger’ regression tests revealed no significant publication bias (p = .44). The pooled estimated prevalence of migraine (55%) was higher in comparison with that of tension‐type headache (20%). The prevalence of migraine subtype was 16% and 10% for migraine without aura and migraine with aura, respectively. The pooled prevalence of primary headache in case–control group (57%) was approximately in line with the cross‐sectional group (56%).Conclusion: The overall prevalence of primary headaches among patients with MS was considerably high. Clinical screening of headache among patients with MS will be helpful to formulate an individualized treatment plans and alleviate the physical and mental impact of the disease.

31 August 2012 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
LLLiang-Yong Li
Liang-Yong Li
JLJia-Lin Li
Jia-Lin Li
HZHui-Min Zhang
Hui-Min Zhang
WYWen-Ming Yang
Wen-Ming Yang
KWKai Wang
Kai Wang
YWYu Wang
Yu Wang

13 February 2014 in NeuroMolecular Medicine
Verified
Journal Article
Closed access
PDF file
CYChuan-Yong Yu
Chuan-Yong Yu
WGWei Gui
Wei Gui
HHHui-Yan He
Hui-Yan He
XWXiao-Shan Wang
Xiao-Shan Wang
JZJian Zuo
Jian Zuo
YWYu Wang
Yu Wang

14 March 2016 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
QWQian-Qian Wang
Qian-Qian Wang
LZLi-Jun Zhu
Li-Jun Zhu
XWXian-Hong Wang
Xian-Hong Wang
JZJian Zuo
Jian Zuo
HHHui-Yan He
Hui-Yan He
YWYu Wang
Yu Wang